Redenlab
Camden, Delaware, United States
Redenlab is a neuroscience technology company specializing in speech and language biometrics to enhance decision-making in clinical trials. They offer cognitive-linguistic tests that are valid, quick, and reliable, capable of detecting subtle disease or treatment-induced changes. Their solutions support in-clinic, in-home, and virtual trials across various neurological conditions. By leveraging artificial intelligence and software, Redenlab provides objective, scalable measurements of speech, language, and swallowing to optimize trial endpoints and deliver meaningful data for pharmaceutical sponsors and researchers.
Company Info
- Founded
- 2017
- Website
- redenlab.com/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Redenlab?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.